Marc Beer is a well-accomplished individual that has currently taken to biotech and pharmaceutical pursuits. Just two years ago, Marc Beer started off the company Renovia along with two colleagues of his, which is focused on research and developing treatments for women all over the world. In the latest series of funding conducted by Marc Beer at Renovia, they managed to get more than 40 million dollars to go towards new research and the development of new treatments for pelvic floor disorders, which currently afflicts more than 250 million women across the world. Marc Beer is dedicated to his mission to help people around the world through his knowledge and discovery and Renovia is his first true legitimate display of that.

 

The funding for Renovia has come from various sources since the company first started up, though in the last series of funding the majority of the money came from investors that want to help the healthcare industry. Roughly 10 million dollars of funding came from debt financing as part of the deal. Various other healthcare organizations have expressed interest and invested in Renovia since it first started, including OSF Ventures, Longwood Fund, Western Technology Investment, and Ascension Ventures. Renovia is currently based out of Boston in the United States and in the past two years since it first started, it has gained tremendous traction throughout the region.

 

Since 2016, Renovia has managed to get the approval of one drug for treating pelvic floor disorders in women known as Leva. The FDA approved this drug without any hassle at all and it will be the first line for treating women with pelvic floor disorders. Leva also uses technology to check urinary tissues inside of the body to see what kind of responses they have normally and with the drug.

 

Marc beer is more than Renovia’s founder, he is also the current Chief Executive Officer and chairman of the board at the company. Marc has spent more than two decades moving in an out of the biotech industry, focusing on development, research, commercialization, and more. On top of his successful career as an entrepreneur, businessman, and healthcare enthusiast, Marc is a dedicated husband and father. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing